Farallon Capital Management Adds $15M in Tenet Healthcare Corporation ($THC)
Key Points
- Farallon Capital Management changed its Tenet Healthcare Corporation ($THC) stake by 21.50% last quarter, boosting to 452,153 shares worth $84.59 million.
- Wall Street's consensus rating on $THC is Strong Buy and an average price target of $285.10.
- $THC last traded around $187.08.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Farallon Capital Management increased its position in Tenet Healthcare Corporation ($THC) by 21.50% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 452,153 shares of Tenet Healthcare Corporation after buying 80,000 shares during the quarter. Farallon Capital Management's holdings in Tenet Healthcare Corporation were worth $84.59 million as of its most recent filing.
Tenet Healthcare Corporation Stock Down 29.9%
Shares of Tenet Healthcare Corporation ($THC) traded around $187.08 on Sunday, down 29.9% for the day.
Tenet Healthcare Corporation Earnings
Analysts Set New Price Targets
About Tenet Healthcare Corporation
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; pediatric quaternary care services through heart, liver, and kidney transplants programs; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services comprising orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. Further, the company operates acute care and specialty hospitals, off-campus emergency departments, imaging centers, urgent care centers, and micro-hospitals, as well as ambulatory surgery centers and surgical hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
Get Tenet Healthcare Corporation alerts
New 13F filings, insider trades, and analyst moves on $THC, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.